Niklas Mattsson-Carlgren, MD, PhD
Lund University, Sweden
- 1 edition
- 1 talk
2024
- Symposium Plasma biomarker strategy for selecting patients for anti-amyloid immunotherapies and determining treatment response
Degrees and affiliation are current where known; the program pages show affiliations as they were each year.